Bionano genomics, inc (BNGO)
Balance Sheet / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Dec'17
Assets
Current assets:
Cash and cash equivalents

17,311

8,200

15,294

20,830

16,522

20,657

1,021

Accounts receivable, net

6,333

6,000

4,983

4,057

4,514

4,000

3,352

Inventory

3,443

2,595

3,022

1,405

1,068

2,614

1,693

Prepaid Expense and Other Assets, Current

1,169

1,018

631

1,720

919

1,347

1,071

Total current assets

28,258

17,839

23,931

28,014

23,025

28,620

7,139

Property and equipment, net

1,949

1,367

1,278

1,537

1,777

2,049

3,005

Total assets

30,207

19,207

25,210

29,551

24,802

30,669

10,145

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

2,699

2,634

3,617

870

1,351

2,363

2,302

Accrued expenses

3,225

3,432

2,702

3,628

2,900

2,815

3,508

Deferred revenue

-

417

421

-

-

-

-

Line of credit

-

953

799

-

-

-

-

Contract liabilities

357

-

-

213

270

335

211

Preferred stock warrant liability

-

-

-

-

-

0

3,898

Current portion of long-term debt

20,084

-

-

-

0

0

6,729

Total current liabilities

26,367

7,437

7,541

4,713

4,522

5,514

16,652

Long-term debt, net of current portion

0

18,777

18,621

18,375

9,029

9,008

0

Long-term deferred revenue

-

224

219

-

-

-

-

Long-term contract liabilities

182

-

-

304

304

144

142

Other non-current liabilities

44

147

173

287

808

767

567

Total liabilities

26,594

26,585

26,555

23,681

14,665

15,434

17,362

Commitments and contingencies (Note 9)

-

-

-

-

-

0

-

Stockholders’ equity:
Common stock, $0.0001 par value, 200,000,000 shares authorized at December 31, 2019 and December 31, 2018; 34,274,469 and 10,055,072 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively

3

1

1

1

1

1

0

Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of December 31, 2019 and 2018

0

-

-

0

0

0

0

Additional paid-in capital

106,187

87,297

86,932

86,483

82,898

81,584

4,038

Retained Earnings (Accumulated Deficit)

-102,577

-94,676

-88,278

-80,614

-72,762

-66,350

-54,266

Total stockholders’ equity

3,613

-7,378

-1,344

5,870

10,137

15,235

-50,227

Total liabilities and stockholders’ equity

30,207

19,207

25,210

29,551

24,802

30,669

10,145

Series A Convertible Preferred Stock
Convertible preferred stock

-

-

-

-

-

-

61

Series B Convertible Preferred Stock
Convertible preferred stock

-

-

-

-

-

-

842

Series B-1 Convertible Preferred Stock
Convertible preferred stock

-

-

-

-

-

-

359

Series C Convertible Preferred Stock
Convertible preferred stock

-

-

-

-

-

-

5,547

Series D Convertible Preferred Stock
Convertible preferred stock

-

-

-

-

-

-

4,838

Series D-1 Convertible Preferred Stock
Convertible preferred stock

-

-

-

-

-

-

31,359